推薦產品
product name
Ascentis® Express Peptide ES-C18, 2.7μm 毛细管 HPLC 色谱柱, 2.7 μm particle size, L × I.D. 15 cm × 1 mm
材料
stainless steel column
agency
suitable for USP L1
產品線
Ascentis®
特點
endcapped: no
製造商／商標名
Ascentis®
包裝
1 ea of
參數
≤100 °C temp. range
技術
HPLC: suitable
LC/MS: suitable
UHPLC-MS: suitable
UHPLC: suitable
長度 × 內徑
15 cm × 1 mm
表面積
90 m2/g
雜質
<5 ppm metals
基質
Fused-Core particle platform
superficially porous particle
基質活性組
C18 (octadecyl) phase
粒徑
2.7 μm
孔徑
160 Å
pH值範圍
1-9
分離技術
reversed phase
尋找類似的產品？ 前往 產品比較指南
法律資訊
Ascentis is a registered trademark of Merck KGaA, Darmstadt, Germany
儲存類別代碼
11 - Combustible Solids
水污染物質分類（WGK）
WGK 3
閃點（°F）
Not applicable
閃點（°C）
Not applicable
從最近期的版本中選擇一個：
分析證明 (COA)
Lot/Batch Number
Meiyun Shi et al.
Journal of separation science, 38(8), 1351-1357 (2015-01-30)
The pentapeptide thymopentin (Arg-Lys-Asp-Val-Tyr, RKDVY) corresponds to amino acids 32-36 of the 49 amino acid immunomodulatory polypeptide, thymopoietin, whose biological activity is partially reproduced. Thymopentin is widely used in the clinic and represents a promising target for drug design but
E Lesellier
Journal of chromatography. A, 1266, 34-42 (2012-11-03)
The recent introduction of new stationary phases for liquid chromatography based on superficially porous particles, called core-shell or fused-core, dramatically improved the separation performances through very high efficiency, due mainly to reduced eddy diffusion. However, few studies have evaluated the
C Gröer et al.
Journal of pharmaceutical and biomedical analysis, 100, 393-401 (2014-09-15)
Cytochrome P450 (CYP) enzymes and UDP-glucuronosyltransferases (UGT) are major determinants in the pharmacokinetics of most drugs on the market. To investigate their impact on intestinal and hepatic drug metabolism, we developed and validated quantification methods for nine CYP (CYP1A2, CYP2B6
我們的科學家團隊在所有研究領域都有豐富的經驗，包括生命科學、材料科學、化學合成、色譜、分析等.
聯絡技術服務